Christopher Keenan | Vice President, Investor Relations |
Sean McCarthy | President, Chief Executive Officer & Chairman |
Robin Knifsend | Vice President, Finance |
Varun Kumar | Cantor Fitzgerald |
Peter Lawson | SunTrust Robinson |
Robert Burns | H.C. Wainwright |
Mohit Bansal | Citigroup |
Biren Amin | Jefferies |
Gabriel Fung | Mizuho Securities |
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics Second Quarter 2019 Financials Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded.
I would not like to introduce your host for today's conference call, Mr.